Clinical trial
Efficacy Study of T Cell Vaccination in HIV Infection
NCT00407836 · Soroka University Medical Center, Other · Completed
Key facts
| NCT number | NCT00407836 |
|---|---|
| Title | Efficacy Study of T Cell Vaccination in HIV Infection |
| Official title | Phase II Study of Efficacy, Tolerability and Safety of CD4-Specific T-cell Vaccine in HIV Infection |
| Lead sponsor | Soroka University Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | T cell vaccination |
| Enrollment | 40 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Dec 5, 2006 |
| Last update posted | Dec 2, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: